Olanzapină Teva (Olanzapine)

Olanzapine, the active ingredient in Olanzapina Teva, is an atypical antipsychotic presented as a tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olanzapina Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapina Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine is an atypical antipsychotic that modulates neurotransmission in psychotic and mood disorders. - Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Bipolar I disorder (manic episodes): Controls acute mania and maintains mood stability. - Schizoaffective disorder: Alleviates psychotic features and stabilises mood swings. - Psychotic depression: Enhances antidepressant response when used as an adjunct. - Tourette syndrome: Decreases frequency and severity of motor and vocal tics. - Autism spectrum disorder irritability: Reduces irritability and aggression.

Olanzapine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Hyperglycaemia and new‑onset diabetes mellitus - Orthostatic hypotension - Seizures - Elevated liver enzymes

Olanzapine should be used with careful clinical monitoring and patient education. - Monitor: Regular blood glucose and lipid profiles to assess metabolic changes. - Assess: Evaluate          ...  ... ... ... ... ... … ... ... … ... … … … … … … … … … … … … … … … … … … … … …   -    ... ... ... ... ... ... ... ... ... ...  …  -  … … … ".  …   "); -  -  -  """  """  "mechan  " """ """  ewline - ullet  "" ");"". -  e """  ewline "". - " "" "" "...